TipRanks
Go Ultimate55% OFF

Abeona Therapeutics (PCJ) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PCJ Analyst Ratings

Strong Buy
4Ratings
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Abeona Therapeutics in the past 3 months

PCJ Stock 12 Month Forecast

EUR 19.69▲(391.47% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Abeona Therapeutics in the last 3 months. The average price target is EUR 19.69 with a high forecast of EUR 26.85 and a low forecast of EUR 15.22. The average price target represents a 391.47% change from the last price of EUR 4.01.
Highest Price TargetEUR 26.85Average Price TargetEUR 19.69Lowest Price TargetEUR 15.22

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:PCJ
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
H.C. WainwrightEUR 17.90buy346.79%UpsideReiterated09/25/26
Roth MKMEUR 15.22buy279.77%UpsideInitiated09/19/26
Cantor FitzgeraldEUR 25.06→EUR 26.85buy570.19%UpsideReiterated09/17/26
Oppenheimer Analyst forecast on DE:PCJUnknown AnalystNot RankedOppenheimerEUR 18.80buy369.13%UpsideReiterated08/14/26
Jefferies Analyst forecast on DE:PCJUnknown AnalystNot RankedJefferiesEUR 15.22buy279.77%UpsideReiterated05/14/26
Alliance Global PartnersEUR 17.90buy346.79%UpsideReiterated05/13/26
Stifel NicolausEUR 15.22buy279.77%UpsideReiterated03/18/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Abeona Therapeutics

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate7/14 ratings generated profit
50%
Average Return
-4.74%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -4.74% per trade.

1 Year
Kristen Kluska
Kristen KluskaCantor Fitzgerald
Success Rate3/9 ratings generated profit
33%
Average Return
-11.71%

Copying Kristen Kluska's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -11.71% per trade.

2 Years
Kristen Kluska
Kristen KluskaCantor Fitzgerald
Success Rate3/9 ratings generated profit
33%
Average Return
+4.64%

Copying Kristen Kluska's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +4.64% per trade.

PCJ Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for PCJ
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy55377
Buy00000
Hold00000
Sell00000
Strong Sell00000
total55377

In the current month, PCJ has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PCJ average Analyst price target in the past 3 months is 19.69.

PCJ Financial Forecast

EUR -2EUR -1.5EUR -1EUR -0.5EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.04
ConsensusEUR -0.16
LowEUR -0.22

PCJ Earnings Forecast

Next quarter’s earnings estimate for PCJ is -EUR 0.16 with a range of -EUR 0.22 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.31. PCJ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PCJ has Performed in-line its overall industry.

EUR -1EUR 4.8MEUR 9.6MEUR 14.5MEUR 19.3MQ4 2025Q2 2026Q3 2026
HighEUR 19.3M
ConsensusEUR 13.2M
LowEUR 10.2M

PCJ Sales Forecast

Next quarter’s sales forecast for PCJ is EUR 13.22M with a range of EUR 10.17M to EUR 19.28M. The previous quarter’s sales results were EUR 10.16M. PCJ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PCJ has Performed in-line its overall industry.

PCJ Stock Forecast FAQ

What is DE:PCJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Abeona Therapeutics’s 12-month average price target is €19.69.
What is DE:PCJ’s upside potential, based on the analysts’ average price target?
Abeona Therapeutics has 391.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Abeona Therapeutics a Buy, Sell or Hold?
Abeona Therapeutics has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Abeona Therapeutics’s share price target?
The average share price target for Abeona Therapeutics is €19.69. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €26.85, and the lowest forecast is €15.22. The average share price target represents a 391.47% increase from the current price of €4.007.
What do analysts say about Abeona Therapeutics?
Abeona Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Abeona Therapeutics?
To buy shares of DE:PCJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.